Proteomics furthers test commercialisation
Perth biotechnology group Proteomics International Laboratories (ASX: PIL) has further developed markets for its test technology snd test kits with news it would be sold in Europe. The company announced its PromarkerD test system to predict the onset of diabetic kidney disease would be sold in Spain under a deal with Patia Europe. The company…